Alkermes
preclinical efforts inform the clinical development strategy preclinical research clinical research molecular design confirmed selectivity demonstrated efficacy first in human studies signal seeking studies receptor selectivity maintained potency cell cell expansion minimal expansion of combination with anti mouse determined recommended phase dose from safety and data responses in multiple tumor types and in combination with anti pivotal studies combination with demonstrate efficacy with complementary mechanisms growth factor pathway inhibitors chemotherapy radiation other agents sab at a oft | Alkermes
Company
Deck Type
Sector
Industry
Deck date
March 2021
Slide
89 of 144
Similar slides by Alkermes
See diffirences between slides (animation)
Investor Day
March 2021
preclinical efforts inform the clinical development strategy preclinical research clinical research molecular design confirmed selectivity demonstrated efficacy first in human studies signal seeking studies receptor selectivity maintained potency cell cell expansion minimal expansion of combination with anti mouse determined recommended phase dose from safety and data responses in multiple tumor types and in combination with anti pivotal studies combination with demonstrate efficacy with complementary mechanisms potential expansion of clinical program growth factor pathway inhibitors chemotherapy radiation other agents new combinations new indications new collaborations a sab at oft | Alkermes
Related slides by other companies
Oculis
Investor Presentation
July 2023
efficacy and safety of ophthalmic suspension eye drops in uveitic and post surgical macular edema the leopard study leopard | Oculis
BioAtla
Investor Presentation
January 2024
cab phase mono and study currently underway | BioAtla
Ocuphire Pharma
Results
October 2022
preclinical enabling studies | Ocuphire Pharma
DICE Therapeutics
Investor Presentation
March 2023
key from phase efficacy results dice | DICE Therapeutics
Other recent decks by Alkermes
See all presentations (22 decks)
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io